Neuland Labs in Trouble? SEBI Issues Warning Over Insider Trading Breach

Neuland Laboratories Limited is officially informing the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) about a recent regulatory communication received by it from the Securities and Exchange Board of India (SEBI). On June 17, 2025, the company sent a formal disclosure in accordance with the provisions of Regulation 30 of SEBI Listing Regulations, read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Regulations. Under this regulation, companies that have received any material communication or action from SEBI must inform BSE and NSE.

In reference to the information, the Deputy General Manager of SEBI has issued an administrative warning letter to the company, i.e., Neuland Laboratories Limited. The administrative warning letter was addressed to the compliance officer of the company regarding the violation of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations). The issue involves a specific person in the company who is said to have broken the pre-clearance requirement. This rule states that they must get approval before making trades in the company’s securities.

The administrative warning letter was issued on June 13, 2025, and the company received it on June 17, 2025. The company clarified that the breach relates only to non-compliance with the pre-clearance process, and thus, no further regulatory or penal action has been reported to date. Neuland Laboratories Limited has stated that this incident will not have a material impact on the company’s financials, operations, or other activities.

This notice is now part of the company records and has been made public by the exchanges.